We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+10.04%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$37.9B
AUM Growth
Cap. Flow
+$36.1B
Cap. Flow %
95.33%
Top 10 Hldgs %
21.49%
Holding
1,659
New
1,659
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.39B
2
AAPL icon
Apple
AAPL
+$1.38B
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$896M
4
AMZN icon
Amazon
AMZN
+$820M
5
JNJ icon
Johnson & Johnson
JNJ
+$601M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 19.62%
2 Healthcare 15.12%
3 Financials 15.09%
4 Consumer Discretionary 10.34%
5 Industrials 9.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GEOS icon
1576
Geospace Technologies
GEOS
$91.6M
$334K ﹤0.01%
+19,935
New +$303K
CONN
1577
DELISTED
Conn's Inc.
CONN
$332K ﹤0.01%
+26,800
New +$561K
DBRG icon
1578
DigitalBridge
DBRG
$2.94B
$331K ﹤0.01%
+17,415
New +$359K
GRTX
1579
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$329K ﹤0.01%
+25,000
New +$305K
MCS icon
1580
Marcus Corp
MCS
$732M
$321K ﹤0.01%
+10,100
New +$342K
CHRS icon
1581
Coherus Oncology
CHRS
$217M
$319K ﹤0.01%
+17,734
New +$327K
HALO icon
1582
Halozyme
HALO
$9.72B
$316K ﹤0.01%
+17,847
New +$309K
TBPH icon
1583
Theravance Biopharma
TBPH
$874M
$315K ﹤0.01%
+12,162
New +$236K
APLS
1584
DELISTED
Apellis Pharmaceuticals
APLS
$314K ﹤0.01%
+10,228
New +$283K
LOPE icon
1585
Grand Canyon Education
LOPE
$3.71B
$314K ﹤0.01%
+3,279
New +$303K
TBIO
1586
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$308K ﹤0.01%
+37,849
New +$349K
ONC
1587
BeOne Medicines Ltd
ONC
$33.8B
$307K ﹤0.01%
+1,850
New +$307K
BLU
1588
DELISTED
BELLUS Health Inc.
BLU
$306K ﹤0.01%
+40,313
New +$276K
PLAB icon
1589
Photronics
PLAB
$1.79B
$295K ﹤0.01%
+18,700
New +$235K
OFIX icon
1590
Orthofix Medical
OFIX
$455M
$291K ﹤0.01%
+6,300
New +$296K
SENEA icon
1591
Seneca Foods Class A
SENEA
$1.13B
$291K ﹤0.01%
+7,133
New +$257K
OVV icon
1592
Ovintiv
OVV
$17.5B
$290K ﹤0.01%
+12,388
New +$265K
FF icon
1593
Future Fuel
FF
$204M
$282K ﹤0.01%
+22,799
New +$272K
FATE icon
1594
Fate Therapeutics
FATE
$281M
$279K ﹤0.01%
+14,273
New +$227K
ANDE icon
1595
Andersons Inc
ANDE
$2.65B
$276K ﹤0.01%
+10,900
New +$238K
YMAB
1596
DELISTED
Y-mAbs Therapeutics
YMAB
$275K ﹤0.01%
+8,801
New +$260K
HT
1597
DELISTED
Hersha Hospitality Trust Priority Class A Common Shares of Beneficial Interest
HT
$274K ﹤0.01%
+18,800
New +$267K
APPF icon
1598
AppFolio
APPF
$5.85B
$273K ﹤0.01%
+2,480
New +$253K
DOCU
1599
DocuSign
DOCU
$9.63B
$271K ﹤0.01%
+3,659
New +$251K
VTOL icon
1600
Bristow Group
VTOL
$1.35B
$270K ﹤0.01%
+13,284
New +$263K

Similar funds

Ensign Peak Advisors's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Ensign Peak Advisors, which disclosed 1,659 positions worth $37.9B. Its ten largest holdings account for 21% of the portfolio.

Its largest position is Microsoft: 9,487,124 shares worth $1.5B.

By sector, the portfolio is most concentrated in Technology at 20% of assets, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q4 2019 buy was Microsoft: 9,487,124 shares worth $1.5B.
  • Ensign Peak Advisors's ten largest holdings make up 21% of its $37.9B portfolio in Q4 2019.
  • Ensign Peak Advisors disclosed 1,659 positions in Q4 2019, its first 13F filing on record.

Based on Ensign Peak Advisors's 13F filing for Q4 2019, filed 14 Feb 2020.